RxNorm Semantic Concepts Index - 230
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "230".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 2300541 | Genetically modified virus | Designated preferred name (PT) | NO | |
| RxCUI: 2300541 | Genetically modified virus | Full form of descriptor (FN) | NO | |
| RxCUI: 23015 | Diethylthiourea | Designated preferred name (PT) | NO | |
| RxCUI: 23015 | Diethylthiourea | Full form of descriptor (FN) | NO | |
| RxCUI: 23015 | Diethylthiourea | Designated preferred name (PT) | NO | |
| RxCUI: 23015 | Diethylthiourea | Full form of descriptor (FN) | NO | |
| RxCUI: 2302 | Substance with chelating agent mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2302 | Substance with chelating agent mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2302 | Substance with chelating agent mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2302 | Substance with chelating agent mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2302 | Substance with chelating agent mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 23020 | difebarbamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 23021 | Difenacoum | Designated preferred name (PT) | NO | |
| RxCUI: 23021 | Difenacoum | Full form of descriptor (FN) | NO | |
| RxCUI: 23024 | difenoxin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 23024 | difenoxin | Designated preferred name (PT) | YES | |
| RxCUI: 23024 | difenoxin | Full form of descriptor (FN) | YES | |
| RxCUI: 23028 | Transferrin reductase | Designated preferred name (PT) | NO | |
| RxCUI: 23028 | Transferrin reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 23028 | Transferrin reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 230307 | Sucrose 1^F^-fructosyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 230307 | Sucrose 1^F^-fructosyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 230308 | 1,2-beta-fructan 1^F^-fructosyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 230308 | 1,2-beta-fructan 1^F^-fructosyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 23033 | diflorasone diacetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 23033 | diflorasone diacetate | Designated preferred name (PT) | YES | |
| RxCUI: 23033 | diflorasone diacetate | Full form of descriptor (FN) | YES | |
| RxCUI: 23035 | diflucortolone valerate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 23035 | diflucortolone valerate | Designated preferred name (PT) | NO | |
| RxCUI: 23035 | diflucortolone valerate | Full form of descriptor (FN) | NO | |
| RxCUI: 23043 | difluprednate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 23043 | difluprednate | Designated preferred name (PT) | YES | |
| RxCUI: 23043 | difluprednate | Full form of descriptor (FN) | YES | |
| RxCUI: 23043 | difluprednate | Designated preferred name (PT) | YES | |
| RxCUI: 23043 | difluprednate | Full form of descriptor (FN) | YES | |
| RxCUI: 230435 | technetium (99mTc) arcitumonmab | Designated preferred name (PT) | NO | |
| RxCUI: 230435 | technetium (99mTc) arcitumonmab | Full form of descriptor (FN) | NO | |
| RxCUI: 230435 | technetium (99mTc) arcitumonmab | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 230435 | technetium (99mTc) arcitumonmab | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2304467 | Antigen of Neisseria meningitidis serogroup Y | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2304467 | Antigen of Neisseria meningitidis serogroup Y | Full form of descriptor (FN) | NO | |
| RxCUI: 2304467 | Antigen of Neisseria meningitidis serogroup Y | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2304467 | Antigen of Neisseria meningitidis serogroup Y | Designated preferred name (PT) | NO | |
| RxCUI: 2304619 | 11-oxy-17-ketosteroid | Designated preferred name (PT) | NO | |
| RxCUI: 2304619 | 11-oxy-17-ketosteroid | Full form of descriptor (FN) | NO | |
| RxCUI: 2305602 | Adhesive agent | Designated preferred name (PT) | NO | |
| RxCUI: 2305602 | Adhesive agent | Full form of descriptor (FN) | NO | |
| RxCUI: 23066 | Porfimer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 23066 | Porfimer | Designated preferred name (PT) | YES | |
| RxCUI: 23066 | Porfimer | Full form of descriptor (FN) | YES | |
| RxCUI: 23066 | Porfimer | Designated preferred name (PT) | YES | |
| RxCUI: 23066 | Porfimer | Full form of descriptor (FN) | YES | |
| RxCUI: 2307890 | BRL 2064 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 230811 | Isoflavone 2'-hydroxylase | Designated preferred name (PT) | NO | |
| RxCUI: 230811 | Isoflavone 2'-hydroxylase | Full form of descriptor (FN) | NO | |
| RxCUI: 230846 | Xanthan lyase | Designated preferred name (PT) | NO | |
| RxCUI: 230846 | Xanthan lyase | Full form of descriptor (FN) | NO | |
| RxCUI: 23088 | dihydrocodeine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 23088 | dihydrocodeine | Designated preferred name (PT) | YES | |
| RxCUI: 23088 | dihydrocodeine | Full form of descriptor (FN) | YES | |
| RxCUI: 23088 | dihydrocodeine | Designated preferred name (PT) | YES | |
| RxCUI: 23088 | dihydrocodeine | Full form of descriptor (FN) | YES | |
| RxCUI: 2309091 | Sodium (C-14) glycocholate | Designated preferred name (PT) | NO | |
| RxCUI: 2309091 | Sodium (C-14) glycocholate | Full form of descriptor (FN) | NO | |
| RxCUI: 2309670 | Hypothalamic inhibiting factor | Designated preferred name (PT) | NO | |
| RxCUI: 2309670 | Hypothalamic inhibiting factor | Full form of descriptor (FN) | NO | |
| RxCUI: 23099 | Dihydrodipicolinate reductase | Designated preferred name (PT) | NO | |
| RxCUI: 23099 | Dihydrodipicolinate reductase | Full form of descriptor (FN) | NO |